This case discusses Susan, a 20-year-old female college student with alcohol use disorder, and explores the practical considerations that should be taken into account when prescribing pharmacotherapy for alcohol use disorder in the adolescent and young adult patient population. It reviews the indications, mechanisms of action, dosing, and current evidence base for acamprosate, naltrexone, and disulfiram.
Pharmacotherapy Alcohol use disorder Adolescent Acamprosate Naltrexone Disulfiram
This is a preview of subscription content, log in to check access.
Plosker GL. Acamprosate: a review of its use in alcohol dependence. Drugs. 2015;75(11):1255–68.CrossRefGoogle Scholar
Stahl SM, Grady MM, Muntner M. Stahl’s essential psychopharmacology: the prescriber's guide, vol. 1–2. 4th ed. New York: Cambridge University Press; 2014. p. 195–7.Google Scholar
Niederhofer H, Staffen W. RETRACTED ARTICLE: acamprosate and its efficacy in treating alcohol dependent adolescents. Eur Child Adolesc Psychiatry. 2003;12(3):144–8.CrossRefGoogle Scholar
Fishman MJ, Winstanley EL, Curran E, et al. Treatment of opioid dependence in adolescents and young adults with extended release naltrexone: preliminary case-series and feasibility. Addiction. 2010;105(9):1669–76.CrossRefGoogle Scholar
Lifrak PD, Alterman AI, O’Brien CP, et al. Naltrexone for alcoholic adolescents. Am J Psychiatry. 1997;154(3):439–41.PubMedGoogle Scholar
Deas D, May MP, Randall C, et al. Naltrexone treatment of adolescent alcoholics: an open-label pilot study. J Child Adolesc Psychopharmacol. 2005;15(5):723–8.CrossRefGoogle Scholar
Niederhofer H, Staffen W. Comparison of disulfiram and placebo in treatment of alcohol dependence of adolescents. Drug Alcohol Rev. 2003;22(3):295.CrossRefGoogle Scholar
Brewer C, Streel E, Skinner M. Supervised disulfiram’s superior effectiveness in alcoholism treatment: ethical, methodological, and psychological aspects. Alcohol Alcohol. 2017;52(2):213–9.PubMedGoogle Scholar